ArticleOncoTargets and therapy2019

Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma.

Huanrong Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.